DeepTek.ai unveiled its groundbreaking Augmento X-Ray, a Computer-Aided Detection (CADe) Chest X-Ray AI solution, during the Radiology Society of North America’s (RSNA) 109th Annual Meeting. Augmento X-Ray, fueled by the US FDA Cleared CXR AI, aims to transform chest X-ray reporting by significantly reducing radiologist workload while enhancing diagnostic accuracy.

This innovative solution seamlessly distinguishes chest radiographs with suspicions from those without, a pivotal step in alleviating the backlog of chest X-rays, thereby streamlining radiology workflows and ultimately elevating patient care.

Augmento X-Ray harnesses the power of the US FDA Cleared AI solution CXR Analyzer, offering comprehensive coverage of the entire chest area. It conducts a thorough analysis, spanning lung, pleura, cardiac findings, as well as the detection of foreign bodies and hardware within the chest.

Ajit Patil, Co-Founder of DeepTek, highlighted the significance of Augmento X-Ray, stating, “Augmento X-Ray marks a significant milestone in AI-powered medical imaging. With the US FDA clearance, its availability in the US market is a monumental step. We're eager to extend our footprint in this critical market, assisting healthcare providers in delivering enhanced patient care.”

The introduction of Augmento X-Ray at RSNA 2023 showcases a pioneering approach in medical imaging, promising to reshape the landscape of chest X-ray analysis. With its ability to improve diagnostic efficiency and accuracy, DeepTek's Augmento X-Ray stands poised to make a transformative impact in radiology practices, benefiting both healthcare professionals and patients alike.